|
1
|
Chen K, Wu K, Jiao X, Wang L, Ju X, Wang
M, Di Sante G, Xu S, Wang Q, Li K, et al: The endogenous cell-fate
factor dachshund restrains prostate epithelial cell migration via
repression of cytokine secretion via a CXCL signaling module.
Cancer Res. 75:1992–2004. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. Ca Cancer J Clin. 54:8–29. 2015.
|
|
3
|
Chaplet M, Waltregny D, Detry C, Fisher
LW, Castronovo V and Bellahcène A: Expression of dentin
sialophosphoprotein in human prostate cancer and its correlation
with tumor aggressiveness. Int J Cancer. 118:850–856. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sung V, Cattell DA, Bueno JM, Murray A,
Zwiebel JA, Aaron AD and Thompson EW: Human breast cancer cell
metastasis to long bone and soft organs of nude mice: A
quantitative assay. Clin Exp Metastasis. 15:173–183. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bellahcène A, Castronovo V, Ogbureke KU,
Fisher LW and Fedarko NS: Small integrin-binding ligand N-linked
glycoproteins (SIBLINGs): Multifunctional proteins in cancer. Nat
Rev Cancer. 8:212–226. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Anunobi CC, Koli K, Saxena G, Banjo AA and
Ogbureke KU: Expression of the SIBLINGs and their MMP partners in
human benign and malignant prostate neoplasms. Oncotarget.
7:48038–48049. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Inoue K, Slaton JW, Eve BY, Kim SJ,
Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA
and Dinney CP: Interleukin 8 expression regulates tumorigenicity
and metastases in androgen-independent prostate cancer. Clin Cancer
Res. 6:2104–2119. 2000.PubMed/NCBI
|
|
8
|
Bellahcène A, Merville MP and Castronovo
V: Expression of bone sialoprotein, a bone matrix protein, in human
breast cancer. Cancer Res. 54:2823–2826. 1994.PubMed/NCBI
|
|
9
|
Neveu B, Moreel X, Deschênes-Rompré MP,
Bergeron A, LaRue H, Ayari C, Fradet Y and Fradet V: IL-8 secretion
in primary cultures of prostate cells is associated with prostate
cancer aggressiveness. Res Reports Urol. 2014:27–34. 2014.
|
|
10
|
Michaud DS, Daugherty SE, Berndt SI, Platz
EA, Yeager M, Crawford ED, Hsing A, Huang WY and Hayes RB: Genetic
polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and
risk of prostate cancer. Cancer Res. 66:4525–4530. 2016. View Article : Google Scholar
|
|
11
|
Goda AE, Koyama M, Sowa Y, Elokely KM,
Yoshida T, Kim BY and Sakai T: Molecular mechanisms of the
antitumor activity of SB225002: A novel microtubule inhibitor.
Biochem Pharmacol. 85:1741–1752. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hamilton SL, Ferando B, Eapen AS, Yu JC
and Joy AR: Cancer secretome may influence BSP and DSP expression
in human salivary gland cells. J Histochem Cytochem. 65:139–151.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
de Vasconcellos JF, Laranjeira AB, Leal
PC, Bhasin MK, Zenatti PP, Nunes RJ, Yunes RA, Nowill AE, Libermann
TA, Zerbini LF and Yunes JA: SB225002 induces cell death and cell
cycle arrest in acute lymphoblastic leukemia cells through the
activation of GLIPR1. PLoS One. 10:e01347832015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Du M, Qiu Q, Gruslin A, Gordon J, He M,
Chan CC, Li D and Tsang BK: SB225002 promotes mitotic catastrophe
in chemo-sensitive and -resistant ovarian cancer cells independent
of p53 status in vitro. PLoS One. 8:e545722013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu M, Jaing H, Wang H, Liu J, Liu B and
Guo Z: SB225002 inhibits prostate cancer invasion and attenuates
the expression of BSP, OPN and MMP-2. Oncol Rep. 40:726–736.
2018.PubMed/NCBI
|
|
17
|
Tu Q, Zhang J, Fix A, Brewer E, Li YP,
Zhang ZY and Chen J: Targeted overexpression of BSP in osteoclasts
promotes bone metastasis of breast cancer cells. J Cell Physiol.
218:135–145. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luca M, Huang S, Gershenwald JE, Singh RK,
Reich R and Bar-Eli M: Expression of interleukin-8 by human
melanoma cells up-regulates MMP-2 activity and increases tumor
growth and metastasis. Am J Pathol. 151:1105–1113. 1997.PubMed/NCBI
|
|
19
|
Pold M, Zhu LX, Sharma S, Burdick MD, Lin
Y, Lee PP, Põld A, Luo J, Krysan K, Dohadwala M, et al:
Cyclooxygenase-2 dependent expression of angiogenic CXC chemokines,
ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8, in human
non-small cell lung cancer. Cancer Res. 64:1853–1860. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mahboob S, Ahn SB, Cheruku HR, Cantor D,
Rennel E, Fredriksson S, Edfeldt G, Breen EJ, Khan A, Mohamedali A,
et al: A novel multiplexed immunoassay identifies CEA, IL-8 and
prolactin as prospective markers for Dukes' stages A-D colorectal
cancers. Clin Proteomics. 12:102015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Freund A, Chauveau C, Brouillet JP, Lucas
A, Lacroix M, Licznar A, Vignon F and Lazennec G: IL-8 expression
and its possible relationship with estrogen-receptor-negative
status of breast cancer cells. Oncogene. 22:256–265. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jain A, Mcknight DA, Fisher LW, Humphreys
EB, Mangold LA, Partin AW and Fedarko NS: Small integrin-binding
proteins as serum markers for prostate cancer detection. Clin
Cancer Res. 15:5199–5207. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang JH, Tang J, Wang J, Ma W, Zheng W,
Yoneda T and Chen J: Over-expression of bone sialoprotein enhances
bone metastasis of human breast cancer cells in a mouse model. Int
J Oncol. 23:1043–1048. 2003.PubMed/NCBI
|
|
24
|
Gordon JA, Sodek J, Hunter GK and Goldberg
HA: Bone sialoprotein stimulates focal adhesion-related signaling
pathways: Role in migration and survival of breast and prostate
cancer cells. J Cell Biochem. 107:1118–1128. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang J, Wang L, Xia B, Yang C, Lai H and
Chen X: BSP gene silencing inhibits migration, invasion, and bone
metastasis of MDA-MB-231BO human breast cancer cells. PLoS One.
8:e629362013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang JH, Wang J, Tang J, Barnett B,
Dickson J, Hahsimoto N, Williams P, Ma W, Zheng W, Yoneda T, et al:
Bone sialoprotein promotes bone metastasis of a non-bone-seeking
clone of human breast cancer cells. Anticancer Res. 24:1361–1368.
2004.PubMed/NCBI
|
|
27
|
Wei RJ, Li TY, Yang XC, Jia N, Yang XL and
Song HB: Serum levels of PSA, ALP, ICTP, and BSP in prostate cancer
patients and the significance of ROC curve in the diagnosis of
prostate cancer bone metastases. Genet Mol Res. 15:2015.
|
|
28
|
Riminucci M, Corsi A, Peris K, Fisher LW,
Chimenti S and Bianco P: Coexpression of bone sialoprotein (BSP)
and the pivotal transcriptional regulator of osteogenesis,
Cbfa1/Runx2, in malignant melanoma. Calcif Tissue Int. 73:281–289.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bellahcène A, Bonjean K, Fohr B, Fedarko
NS, Robey FA, Young MF, Fisher LW and Castronovo V: Bone
sialoprotein mediates human endothelial cell attachment and
migration and promotes angiogenesis. Circ Res. 86:885–891. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Righi L, Bollito E, Ceppi P, Mirabelli D,
Tavaglione V, Chiusa L, Porpiglia F, Brunelli M, Martignoni G,
Terrone C and Papotti M: Prognostic role of bone sialoprotein in
clear cell renal carcinoma. Anticancer Res. 33:2679–2687.
2013.PubMed/NCBI
|
